Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 8, 2001, Pages 977-980

  Pfammatter, Rahel ^a   Quattropani, Christiana ^a   Reichen, Jürg ^a   Göke, Burkhard ^a   Wagner, Andreas C C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hepatic hydrothorax; Keywords; Liver cirrhosis; Liver failure; Octreotide

Indexed keywords

DIURETIC AGENT; OCTREOTIDE; PREDNISONE; STEROID;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CAUSE OF DEATH; CHYLOTHORAX; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HEPATIC COMA; HUMAN; HYDROTHORAX; LABORATORY TEST; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARENTERAL NUTRITION; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX DRAINAGE; TREATMENT FAILURE; TUBE;

CHEST TUBES; DRAINAGE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYDROTHORAX; LIVER CIRRHOSIS; MIDDLE AGED; OCTREOTIDE; VASOCONSTRICTOR AGENTS;

EID: 0034890435     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200108000-00019     Document Type: Article

References (17)

1. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107: 262-267.
2. Alberts WM, Salem AJ, Solomon DA, Boyce G. Hepatic hydrothorax. Cause and management. Arch Intern Med 1991; 151: 2383-2388.
3. Mentes BB, Kayhan B, Gorgul A, Unal S. Hepatic hydrothorax in the absence of ascites: report of two cases and review of the mechanism. Dig Dis Sci 1997; 42: 781-788.
4. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81: 566-567.
5. Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994; 106: 1293-1295.
6. Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 1520-1522.
7. Andrade RJ, Martin-Palanca A, Fraile JM, Alcantara R, Carmona C, Medina MC. et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996; 22: 305-307.
8. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR. et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25: 1366-1369.
9. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46-55.
10. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73-89.
11. Patel NH, Chalasani N, Jindal RM. Current status of transjugular intrahepatic portosystemic shunts. Postgrad Med J 1998; 74: 716-720.
12. Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995; 90: 556-563.
13. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Cole PE. et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 849-857.
14. Nevens F. Resource analysis of somatostatin in the treatment of bleeding esophageal varices. Digestion 1999; 60 (suppl 3): 35-37.
15. Goulis J, Burroughs AK. Role of vasoactive drugs in the treatment of bleeding oesophageal varices. Digestion 1999; 60 (suppl 3): 25-34.
16. Meddi P, Merli M, Lionetti R, De Santis A, Valeriano V, Masini A. et al. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology 1999; 29: 1074-1077.
17. Zacks SL, Sandler RS, Biddle AK, Mauro MA, Brown RSJ. Decision-analysis of transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt for portal hypertension. Hepatology 1999; 29: 1399-1405.